Phase II Study of SHJ002 Sterile Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease
A Double-Blinded, Parallel, Vehicle-Controlled Phase 2 Study of SHJ002 Sterile Ophthalmic Solution in Participants With Dry Eye Disease
Sponsor: Dreamhawk Vision Biotech, Inc.
A PHASE2 clinical study on Dry Eye Disease, this trial is completed. The trial is conducted by Dreamhawk Vision Biotech, Inc. and has accumulated 8 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Nov 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Nov 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2024 — Jul 2024 [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
Nov 2023 — Jan 2024 [monthly]
Recruiting PHASE2
▶ Show 3 earlier versions
-
Jun 2023 — Nov 2023 [monthly]
Recruiting PHASE2
-
Apr 2023 — Jun 2023 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Sep 2022 — Apr 2023 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Dreamhawk Vision Biotech, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .